We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Evaluating the Long-Term Effects of Cocoa Extract Supplementation on the Development of Hypertension: Insights from the COSMOS Trial

MedXY Editorial Team•Sep 19, 2025•Clinical Updates
blood pressureHypertensionrandomized clinical trial

Highlight

– The COSMOS randomized clinical trial investigated the long-term impact of cocoa extract supplementation on incident hypertension in older adults.
– Overall, cocoa extract did not significantly reduce hypertension incidence over a median follow-up of 3.4 years.
– A notable 24% reduction in hypertension risk was observed among participants with baseline systolic blood pressure (SBP) below 120 mm Hg.
– The protective effect became apparent after two years of supplementation, highlighting a potential preventive role in normotensive individuals.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension ManagementRecent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.Sep 17, 2026IVIG Plus Prednisone Enhances Recovery in Newly Diagnosed Idiopathic Inflammatory Myopathies: Insights from a Randomized Clinical TrialA recent randomized trial shows that adding intravenous immunoglobulin (IVIG) to high-dose prednisone significantly improves muscle strength and disease activity in newly diagnosed idiopathic inflammatory myopathies with rapid and clinicallSep 17, 2026Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient CohortStudy found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.Sep 17, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Sustained Reduction of Severe Maternal Morbidity and Racial Disparities Through a Statewide Perinatal Quality Collaborative
A Louisiana statewide perinatal quality collaborative significantly reduced severe maternal morbidity related to hemorrhage and hypertension, sustained improvements across initiatives, and narrowed racial disparities, demonstrating durable
Sep 8, 2026
Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical TrialThis review synthesizes evidence from the TEASE-1 trial and related studies on gildeuretinol acetate, highlighting its safety profile and modest efficacy in slowing retinal atrophic lesion growth in Stargardt disease over 24 months.Sep 7, 2026
Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding TrialThe DASH4D diet, a tailored DASH-style intervention for diabetes, significantly improved key glycemic biomarkers including fructosamine, fasting glucose, and HbA1c compared to a typical American diet in adults with type 2 diabetes.Aug 29, 2026